These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2801307)

  • 21. Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions.
    Dumke CL; Kim J; Arias EB; Cartee GD
    J Appl Physiol (1985); 2002 Feb; 92(2):657-64. PubMed ID: 11796678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of leukocytes and endotoxin with the plasmin and kinin systems.
    Miller RL; Webster ME; Melmon KL
    Eur J Pharmacol; 1975 Aug; 33(1):53-60. PubMed ID: 126170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The kallikrein/kinin system in ocular function.
    Webb JG
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):539-43. PubMed ID: 22136090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kinins--characteristics and role in the circulatory system].
    Gabrylewicz B; Tendera M
    Pol Merkur Lekarski; 2004 Dec; 17(102):547-9. PubMed ID: 15771118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of mineralocorticoids, renal prostaglandins and the renal kallikrein-kinin system.
    Nasjletti A; Colina-Chourio J
    Fed Proc; 1976 Feb; 35(2):189-93. PubMed ID: 765163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The kallikrein-kinin system in the acutely-ill: (A) changes in plasma kininogen in acutely-ill patients. (B) the efficacy of pulmonary clearance of bradykinin.
    McConn R; Wasserman F; Haberland G
    Adv Exp Med Biol; 1983; 156 (Pt B)():1019-35. PubMed ID: 6552853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinin-generating cellular model obtained from human glioblastoma cell line U-373.
    Guevara-Lora I; Blonska B; Faussner A; Kozik A
    Acta Biochim Pol; 2013; 60(3):299-305. PubMed ID: 23757449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases.
    Brechter AB; Persson E; Lundgren I; Lerner UH
    Bone; 2008 Jul; 43(1):72-83. PubMed ID: 18467203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current concepts of the role of the kallikrein-kinin system in the pathogenesis of acute arterial obstruction and its sequelae (a review of the Soviet and foreign literature)].
    Chirkova LD; Isaev MR
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):138-41. PubMed ID: 6274077
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of kallikrein-kinin system in central nervous system diseases].
    Stadnicka I; Strzałka-Mrozik B; Solarz K; Stadnicki A
    Wiad Lek; 2018; 71(8):1615-1620. PubMed ID: 30684349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endothelial kinins in control of coronary nitric oxide production.
    Zhang X; Scicli GA; Xu X; Nasjletti A; Hintze TH
    Hypertension; 1997 Nov; 30(5):1105-11. PubMed ID: 9369263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L.
    Desmazes C; Galineau L; Gauthier F; Brömme D; Lalmanach G
    Eur J Biochem; 2003 Jan; 270(1):171-8. PubMed ID: 12492488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bradykinin antagonists: development and applications.
    Stewart JM
    Biopolymers; 1995; 37(2):143-55. PubMed ID: 7893946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis.
    Cassim B; Shaw OM; Mazur M; Misso NL; Naran A; Langlands DR; Thompson PJ; Bhoola KD
    Rheumatology (Oxford); 2009 May; 48(5):490-6. PubMed ID: 19254919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues.
    Ma JX; Song Q; Hatcher HC; Crouch RK; Chao L; Chao J
    Exp Eye Res; 1996 Jul; 63(1):19-26. PubMed ID: 8983960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinins contribute to the contractile effects of rat glandular kallikrein on the isolated rat uterus.
    Orce GG; Carretero OA; Scicli G; Scicli AG
    J Pharmacol Exp Ther; 1989 May; 249(2):470-5. PubMed ID: 2724135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kallikreins and kinins in inflammatory-like events in the reproductive tract.
    Clements J; Mukhtar A; Yan S; Holland A
    Pharmacol Res; 1997 Jun; 35(6):537-40. PubMed ID: 9356205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue kallikreins and kinins: roles in human disease and target for new drug development.
    Margolius HS
    Adv Exp Med Biol; 1989; 247A():1-6. PubMed ID: 2690583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.